Detalles de la búsqueda
1.
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
Circulation
; 141(17): 1360-1370, 2020 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32098501
2.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med
; 377(13): 1228-1239, 2017 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28910237
3.
Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment.
Drug Metab Dispos
; 43(2): 190-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25384899
4.
Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
Circulation
; 138(22): 2576-2578, 2018 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30571356
5.
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.
Diabetes Res Clin Pract
; 183: 109152, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34813910
6.
Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
Diabetes Care
; 43(3): 643-652, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31882409
7.
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Diabetes Care
; 43(2): 374-381, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806653
8.
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
Diabetes Care
; 42(6): 1075-1080, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010875
9.
Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects.
Diabetes Obes Metab
; 10(6): 506-13, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18284437
10.
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial.
J Am Heart Assoc
; 7(19): e009304, 2018 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30371301
11.
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.
Lancet Diabetes Endocrinol
; 6(2): 105-113, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29221659
12.
A fall in portal vein insulin does not cause the alpha-cell response to mild, non-insulin-induced hypoglycemia in conscious dogs.
Metabolism
; 52(11): 1418-25, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14624400
13.
Effects of hyperglycemia, glucagon, and epinephrine on renal glucose release in the conscious dog.
Metabolism
; 53(7): 933-41, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15254890
14.
Effects of multiple doses of the DPP-IV inhibitor PF-734200 on the relationship between GLP-1 and glucose in subjects with type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 91(2): e45-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21130513
15.
Intraportal administration of neuropeptide Y and hepatic glucose metabolism.
Am J Physiol Regul Integr Comp Physiol
; 294(4): R1197-204, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18234742
16.
Stimulation of both type I and type II corticosteroid receptors blunts counterregulatory responses to subsequent hypoglycemia in healthy man.
Am J Physiol Endocrinol Metab
; 294(3): E506-12, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18182467
17.
Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia.
Am J Transplant
; 5(10): 2368-77, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16162184
18.
Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog.
Am J Physiol Endocrinol Metab
; 284(4): E695-707, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12626324
19.
Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
Am J Physiol Endocrinol Metab
; 284(5): E1027-36, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12569088
20.
Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion.
Am J Physiol Endocrinol Metab
; 285(3): E534-44, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12736160
Resultados
1 -
20
de 20
1
Próxima >
>>